Confirmed Control (82%) Closed Transaction verified FoodBeveragesSupplements

GlaxoSmithKline Bangladesh Limited acquired by Unilever PLC

Unilever PLC acquired GlaxoSmithKline Bangladesh Limited, a Bangladesh health food drinks brand, on Jun 30, 2020.

Transaction summary

Target
GlaxoSmithKline Bangladesh Limited
Acquirer
Unilever PLC
Seller
-
Announced
-
Completed
2020-06-30
Geography
Bangladesh
Type
Acquisition
Deal type
Control
Stake acquired
82%
First added
2026-11-08
Latest update
2026-11-08

Value and multiples

100% enterprise value

Undisclosed

Value not disclosed

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

-

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • Enterprise value is unavailable.

Source summary

Unilever 20-F, filed 2022-03-09

Confirmed

Acquisition of GlaxoSmithKline Bangladesh Limited by Unilever PLC.

Open source

Unilever 20-F, filed 2022-03-09

Confirmed

The Group acquired 82 % of GlaxoSmithKline Bangladesh Limited, a health food drink business in Bangladesh. The Bangladesh Horlicks Acquisition was a separate transaction to the Main Horlicks Acquisition.

Open source

Unilever 20-F, filed 2022-03-09

Confirmed

30 June 2020

Open source

Unilever 20-F, filed 2022-03-09

Confirmed

UNILEVER PLC (Exact name of Registrant as specified in its charter)

Open source

Continue your research

Explore more comps →